Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression

NCT01111461 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
133
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Eisai Inc.